Related Experiment Video
Updated: Jul 30, 2026
06:55
Inverse Probability of Treatment Weighting (Propensity Score) using the Military Health System Data Repository and National Death Index
Published on: January 8, 2020
Estimating incremental cost-effectiveness ratios and their confidence intervals with differentially censored data
1Division of Biostatistics and Epidemiology, Department of Public Health Sciences, University of Virginia, Charlottesville, Virginia 22908, USA. hkwang@virginia.edu
Biometrics
|August 22, 2006
Summary
This study introduces a new method for cost-effectiveness analysis in clinical trials with differential censoring. It helps determine the true incremental cost-effectiveness ratio (ICER) for new medical treatments.
Area of Science:
- Health Economics
- Biostatistics
- Clinical Trials
Background:
- Medical costs are rising, necessitating rigorous economic impact assessments for new treatments.
- Cost-effectiveness analysis, using measures like the incremental cost-effectiveness ratio (ICER), is crucial for evaluating healthcare interventions.
- Randomized clinical trials (RCTs) with staggered entries present unique statistical challenges, particularly when cost and survival data have different censoring times.
Purpose of the Study:
- To propose a novel statistical method for estimating the incremental cost-effectiveness ratio (ICER) in the presence of differential censoring for cost and survival data.
- To develop a reliable method for calculating the confidence interval for the ICER under these challenging conditions.
- To address the complexities of cost-effectiveness analysis in clinical trials with staggered patient entries and distinct censoring patterns.
Main Methods:
- Development of a statistical methodology to estimate the ICER when censoring times differ between cost and survival data.
- Utilizing simulation experiments to rigorously evaluate the performance and accuracy of the proposed estimation method.
- Application of the developed method to real-world clinical trial data for practical validation.
Main Results:
- The proposed method accurately estimates the incremental cost-effectiveness ratio (ICER) even with differential censoring.
- Simulation studies demonstrate the robustness and reliability of the developed statistical approach.
- The analysis of the defibrillator trial provides valuable insights into the cost-effectiveness of interventions for post-myocardial infarction patients.
Conclusions:
- The novel method effectively addresses the challenge of differential censoring in cost-effectiveness analysis within clinical trials.
- This approach enhances the accuracy of economic evaluations for new medical treatments.
- The findings support informed decision-making regarding the adoption of new therapies based on their economic value.
Related Concept Videos
01:21Confidence Intervals
An unbiased point estimate is often insufficient to predict a population estimate, such as population mean or population proportion. In this scenario, a confidence interval is used. A confidence interval is an estimate similar to a sample proportion. However, unlike the point estimate which is a single value, the confidence interval contains a range of values. These values have lower and upper limits, known as confidence limits, and can be designated as L1 and L2, respectively.
A confidence...
A confidence...
01:19Interpretation of Confidence Intervals
A confidence interval is a better estimate of the population than a point estimate, as it uses a range of values from a sample instead of a single value.
Confidence intervals have confidence coefficients that are crucial for their interpretation. The most common confidence coefficients are 0.90, 0.95, and 0.99, which can be written as percentages–90%, 95%, and 99%, respectively.
Suppose a person calculates a confidence interval with a confidence coefficient of 0.95. In that case, they can...
Confidence intervals have confidence coefficients that are crucial for their interpretation. The most common confidence coefficients are 0.90, 0.95, and 0.99, which can be written as percentages–90%, 95%, and 99%, respectively.
Suppose a person calculates a confidence interval with a confidence coefficient of 0.95. In that case, they can...
01:24Kaplan-Meier Approach
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
01:15Assumptions of Survival Analysis
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
01:20Comparing the Survival Analysis of Two or More Groups
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and Cox...
01:09Censoring Survival Data
Survival analysis is a statistical method used to analyze time-to-event data, often employed in fields such as medicine, engineering, and social sciences. One of the key challenges in survival analysis is dealing with incomplete data, a phenomenon known as "censoring." Censoring occurs when the event of interest (such as death, relapse, or system failure) has not occurred for some individuals by the end of the study period or is otherwise unobservable, and it might have many different reasons...